Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor ...

Elizabeth Mills of Willow Street and Shannon Zimmerman of Manheim Township have both undergone training and are certified ...

The advantages and disadvantages of CAR-T cell therapy should be carefully thought about for patients with melanoma.

A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...

Updated clinical data from VISTA101 presented at SITC 2024.Monotherapy arm fully enrolled and combination arm expected to be fully enrolled by ...

When American Leadership Academy (ALA) opened in Sierra Vista this past fall, he was offered the opportunity to return to ...

SNS-101 Phase 1/2 dose expansion clinical data expected in the first half of 2025 - - Organizational restructuring to focus ...

Body Mechanics Physical Therapy recently welcomed two new physical therapists to its Buena Vista clinic, strengthening its ...

an anti-VISTA monoclonal antibody, as monotherapy and in combination with Merck’s anti-PD-1 therapy, KEYTRUDA, in patients with advanced solid tumors. KVA12123 cleared all six monotherapy dose levels ...